W.J. and F.-K.J. Berry GT. Disorders of galactose metabolism. W.J. Saudubray JM, Baumgartner MR, eds. Inborn Metabolic Diseases - Diagnosis and Treatment. 6th ed. New York: Springer-Verlag Inc; 2016. 139-47.
F.-K.J. Walter JH. Galactosemia. M.G. Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K (Ed.). The Online Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2014.
Berry GT, Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, et al. Classic Galactosemia and Clinical Variant Galactosemia. 1993. [QxMD MEDLINE Link]. [Full Text].
Segal S. Galactosemia unsolved. Eur J Pediatr. 1995. 154(7 Suppl 2):S97-102. [QxMD MEDLINE Link].
Berry GT. Galactosemia: when is it a newborn screening emergency?. Mol Genet Metab. 2012 May. 106(1):7-11. [QxMD MEDLINE Link].
Berry GT, Elsas LJ. Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia. J Inherit Metab Dis. 2011 Apr. 34(2):249-55. [QxMD MEDLINE Link].
Mason HH, Turner ME. Chronic galactosemia: report of case with studies on carbohydrates. Am J Dis Child. 1935. 50:359-74.
von Reuss A, Zuckerausscheidung im Sauglingsalter, Wien Med Wochenschr. (1908) 7990801.
Komrower GM, Lee DH. Long-term follow-up of galactosaemia. Arch Dis Child. 1970 Jun. 45(241):367-73. [QxMD MEDLINE Link].
Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis. 1990. 13(6):802-18. [QxMD MEDLINE Link].
Waisbren SE, Potter NL, Gordon CM, et al. The adult galactosemic phenotype. J Inherit Metab Dis. 2012 Mar. 35(2):279-86. [Full Text].
Fridovich-Keil J, Bean L, He M, Schroer R, Adam MP, Ardinger HH, et al. Epimerase Deficiency Galactosemia. 1993. [QxMD MEDLINE Link]. [Full Text].
Walter JH, Collins JE, Leonard JV. Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group. Arch Dis Child. 1999 Jan. 80(1):93-6. [QxMD MEDLINE Link].
Fridovich-Keil JL, Gambello MJ, Singh RH, Sharer JD, Adam MP, Ardinger HH, et al. Duarte Variant Galactosemia. 1993. [QxMD MEDLINE Link]. [Full Text].
Langley SD, Lai K, Dembure PP, Hjelm LN, Elsas LJ. Molecular basis for Duarte and Los Angeles variant galactosemia. Am J Hum Genet. 1997 Feb. 60(2):366-72. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Welling L, Bernstein LE, Berry GT, et al. International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis. 2017 Mar. 40 (2):171-176. [QxMD MEDLINE Link].
Garden AS, Davidson DC. Recommendations for the management of galactosaemia. Arch Dis Child. 2000 Mar. 82(3):266. [QxMD MEDLINE Link].
Welling L, Boelen A, Derks TG, Schielen PC, de Vries M, Williams M, et al. Nine years of newborn screening for classical galactosemia in the Netherlands: Effectiveness of screening methods, and identification of patients with previously unreported phenotypes. Mol Genet Metab. 2017 Mar. 120 (3):223-228. [QxMD MEDLINE Link].
Thakur M, Feldman G, Puscheck EE. Primary ovarian insufficiency in classic galactosemia: current understanding and future research opportunities. J Assist Reprod Genet. 2018 Jan. 35 (1):3-16. [QxMD MEDLINE Link].
Shaw KA, Mulle JG, Epstein MP, Fridovich-Keil JL. Gastrointestinal Health in Classic Galactosemia. JIMD Rep. 2017. 33:27-32. [QxMD MEDLINE Link].
Levy HL, Brown AE, Williams SE, de Juan E Jr. Vitreous hemorrhage as an ophthalmic complication of galactosemia. J Pediatr. 1996 Dec. 129(6):922-5. [QxMD MEDLINE Link].
Antshel KM, Epstein IO, Waisbren SE. Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study. Neuropsychology. 2004 Oct. 18(4):658-64. [QxMD MEDLINE Link].
Waisbren SE, Norman TR, Schnell RR, Levy HL. Speech and language deficits in early-treated children with galactosemia. J Pediatr. 1983 Jan. 102(1):75-7. [QxMD MEDLINE Link].
Nelson CD, Waggoner DD, Donnell GN, et al. Verbal dyspraxia in treated galactosemia. Pediatrics. 1991 Aug. 88(2):346-50. [QxMD MEDLINE Link].
Potter NL, Lazarus JA, Johnson JM, Steiner RD, Shriberg LD. Correlates of language impairment in children with galactosaemia. J Inherit Metab Dis. 2008 Aug. 31(4):524-32. [QxMD MEDLINE Link].
Hoffmann B, Wendel U, Schweitzer-Krantz S. Cross-sectional analysis of speech and cognitive performance in 32 patients with classic galactosemia. J Inherit Metab Dis. 2011 Apr. 34(2):421-7. [QxMD MEDLINE Link].
Timmers I, van den Hurk J, Di Salle F, Rubio-Gozalbo ME, Jansma BM. Language production and working memory in classic galactosemia from a cognitive neuroscience perspective: future research directions. J Inherit Metab Dis. 2011 Apr. 34(2):367-76. [QxMD MEDLINE Link]. [Full Text].
ten Hoedt AE, Maurice-Stam H, Boelen CC, Rubio-Gozalbo ME, van Spronsen FJ, Wijburg FA, et al. Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life. J Inherit Metab Dis. 2011 Apr. 34(2):391-8. [QxMD MEDLINE Link]. [Full Text].
Timmers I, van den Hurk J, Hofman PA, Zimmermann LJ, Uludağ K, Jansma BM, et al. Affected functional networks associated with sentence production in classic galactosemia. Brain Res. 2015 Aug 7. 1616:166-76. [QxMD MEDLINE Link].
Davies P, Connor E, MacKenzie J, Jamieson MA. Spontaneous Recovery of Ovarian Function in an Adolescent with Galactosemia and Apparent Premature Ovarian Insufficiency. J Pediatr Adolesc Gynecol. 2015 Aug. 28 (4):e101-3. [QxMD MEDLINE Link].
Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med. 1981 Apr 23. 304(17):994-8. [QxMD MEDLINE Link].
Guerrero NV, Singh RH, Manatunga A, Berry GT, Steiner RD, Elsas LJ 2nd. Risk factors for premature ovarian failure in females with galactosemia. J Pediatr. 2000 Dec. 137(6):833-41. [QxMD MEDLINE Link].
Forges T, Monnier-Barbarino P. [Premature ovarian failure in galactosaemia: pathophysiology and clinical management]. Pathol Biol (Paris). 2003 Feb. 51(1):47-56. [QxMD MEDLINE Link].
Gubbels CS, Land JA, Rubio-Gozalbo ME. Fertility and impact of pregnancies on the mother and child in classic galactosemia. Obstet Gynecol Surv. 2008 May. 63(5):334-43. [QxMD MEDLINE Link].
Frederick AB, Zinsli AM, Carlock G, Conneely K, Fridovich-Keil JL. Presentation, progression, and predictors of ovarian insufficiency in classic galactosemia. J Inherit Metab Dis. 2018 Sep. 41 (5):785-790. [QxMD MEDLINE Link].
Haskovic M, Poot WJ, van Golde RJT, Benneheij SH, Oussoren E, de Wert GMWR, et al. Intrafamilial oocyte donation in classic galactosemia: ethical and societal aspects. J Inherit Metab Dis. 2018 Sep. 41 (5):791-797. [QxMD MEDLINE Link].
van Erven B, Berry GT, Cassiman D, Connolly G, Forga M, Gautschi M, et al. Fertility in adult women with classic galactosemia and primary ovarian insufficiency. Fertil Steril. 2017 Jul. 108 (1):168-174. [QxMD MEDLINE Link].
Berry GT. Galactosemia and amenorrhea in the adolescent. Ann N Y Acad Sci. 2008. 1135:112-7. [QxMD MEDLINE Link].
Schweitzer S, Shin Y, Jakobs C, Brodehl J. Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr. 1993 Jan. 152(1):36-43. [QxMD MEDLINE Link].
Schadewaldt P, Lilburn M, Wendel U, Lee P. Unexpected outcome in untreated galactosaemia. Molecular Genetics and Metabolism. 2004. 81:255-57.
Panis B, Bakker JA, Sels JP, Spaapen LJ, van Loon LJ, Rubio-Gozalbo ME. Untreated classical galactosemia patient with mild phenotype. Mol Genet Metab. 2006 Nov. 89(3):277-9. [QxMD MEDLINE Link].
Elsas LJ 2nd, Langley S, Paulk EM, et al. A molecular approach to galactosemia. Eur J Pediatr. 1995. 154(7 Suppl 2):S21-7. [QxMD MEDLINE Link].
McCorvie TJ, Kopec J, Pey AL, Fitzpatrick F, Patel D, Chalk R, et al. Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase. Hum Mol Genet. 2016 Jun 1. 25 (11):2234-2244. [QxMD MEDLINE Link].
Rubio-Gozalbo ME, Bosch AM, Burlina A, Berry GT, Treacy EP, Steering Committee on behalf of all Galactosemia Network representatives. The galactosemia network (GalNet). J Inherit Metab Dis. 2017 Mar. 40 (2):169-170. [QxMD MEDLINE Link].
Singh R, Thapa BR, Kaur G, Prasad R. Frequency distribution of Q188R, N314D, Duarte 1, and Duarte 2 GALT variant alleles in an Indian galactosemia population. Biochem Genet. 2012 Dec. 50(11-12):871-80. [QxMD MEDLINE Link].
Kozák L, Francová H, Fajkusová L, Pijácková A, Macku J, Stastná S, et al. Mutation analysis of the GALT gene in Czech and Slovak galactosemia populations: identification of six novel mutations, including a stop codon mutation (X380R). Hum Mutat. 2000 Feb. 15 (2):206. [QxMD MEDLINE Link].
Lukac-Bajalo J, Kuzelicki NK, Zitnik IP, Mencej S, Battelino T. Higher frequency of the galactose-1-phosphate uridyl transferase gene K285N mutation in the Slovenian population. Clin Biochem. 2007 Mar. 40 (5-6):414-5. [QxMD MEDLINE Link].
Oliveira TG, Soares-Fernandes JP. Brain MRI in a patient with classical galactosemia: acute event of unilateral hemispheric cerebral edema. Childs Nerv Syst. 2017 Nov. 33 (11):1879-1880. [QxMD MEDLINE Link].
van Erven B, Jansma BM, Rubio-Gozalbo ME, Timmers I. Exploration of the Brain in Rest: Resting-State Functional MRI Abnormalities in Patients with Classic Galactosemia. Sci Rep. 2017 Aug 22. 7 (1):9095. [QxMD MEDLINE Link].
Martinelli D, Bernardi B, Napolitano A, Colafati GS, Dionisi-Vici C. Teaching NeuroImages: Galactitol peak and fatal cerebral edema in classic galactosemia: Too much sugar in the brain. Neurology. 2016 Jan 19. 86 (3):e32-3. [QxMD MEDLINE Link].
Jumbo-Lucioni PP, Garber K, Kiel J, Baric I, Berry GT, Bosch A, et al. Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomes. J Inherit Metab Dis. 2012 Nov. 35(6):1037-49. [QxMD MEDLINE Link].
Anderson S. GALT Deficiency Galactosemia. MCN Am J Matern Child Nurs. 2018 Jan/Feb. 43 (1):44-51. [QxMD MEDLINE Link].
Frederick AB, Cutler DJ, Fridovich-Keil JL. Rigor of non-dairy galactose restriction in early childhood, measured by retrospective survey, does not associate with severity of five long-term outcomes quantified in 231 children and adults with classic galactosemia. J Inherit Metab Dis. 2017 Nov. 40 (6):813-821. [QxMD MEDLINE Link].
Coelho AI, Rubio-Gozalbo ME, Vicente JB, Rivera I. Sweet and sour: an update on classic galactosemia. J Inherit Metab Dis. 2017 May. 40 (3):325-342. [QxMD MEDLINE Link].
Welling L, Waisbren SE, Antshel KM, Colhoun HO, Gautschi M, Grünewald S, et al. Systematic Review and Meta-analysis of Intelligence Quotient in Early-Treated Individuals with Classical Galactosemia. JIMD Rep. 2017. 37:115-123. [QxMD MEDLINE Link].
Coelho AI, Berry GT, Rubio-Gozalbo ME. Galactose metabolism and health. Curr Opin Clin Nutr Metab Care. 2015 Jul. 18 (4):422-7. [QxMD MEDLINE Link].
Portnoi PA, MacDonald A. The lactose and galactose content of milk fats and suitability for galactosaemia. Mol Genet Metab Rep. 2015 Dec. 5:42-43. [QxMD MEDLINE Link].
van Erven B, Welling L, van Calcar SC, Doulgeraki A, Eyskens F, Gribben J, et al. Bone Health in Classic Galactosemia: Systematic Review and Meta-Analysis. JIMD Rep. 2017. 35:87-96. [QxMD MEDLINE Link].
Welling L, Meester-Delver A, Derks TG, Janssen MCH, Hollak CEM, de Vries M, et al. The need for additional care in patients with classical galactosaemia. Disabil Rehabil. 2018 May 31. 1-6. [QxMD MEDLINE Link].
Adam S, Akroyd R, Bernabei S, et al. How strict is galactose restriction in adults with galactosaemia? International practice. Mol Genet Metab. 2015 May. 115 (1):23-6. [QxMD MEDLINE Link].
Knerr I, Coss KP, Kratzsch J, Crushell E, Clark A, Doran P, et al. Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study. Pediatr Res. 2015 Sep. 78 (3):272-9. [QxMD MEDLINE Link].
Van Calcar SC, Bernstein LE, Rohr FJ, Scaman CH, Yannicelli S, Berry GT. A re-evaluation of life-long severe galactose restriction for the nutrition management of classic galactosemia. Mol Genet Metab. 2014 Jul. 112(3):191-7. [QxMD MEDLINE Link].